FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

38738111000001100: Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-Aug 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1502741000001118 Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1502751000001115 Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) Is a Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) Is a Ambelina true Inferred relationship Existential restriction modifier
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) Has specific active ingredient Levonorgestrel true Inferred relationship Existential restriction modifier
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) 63 tablet 3 x 21 tablets Has AMP True Ambelina 150microgram/30microgram tablets (Crescent Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start